Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration
- 31 December 1994
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 12 (3) , 433-442
- https://doi.org/10.1016/0730-725x(94)92537-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Monocrystalline iron oxide nanocompounds (MION): Physicochemical propertiesMagnetic Resonance in Medicine, 1993
- Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent for MRIMagnetic Resonance in Medicine, 1992
- Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.Radiology, 1990
- Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.Radiology, 1990
- A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agentMagnetic Resonance Imaging, 1990
- Relaxation efficacy of paramagnetic and superparamagnetic microspheres in liver and spleenMagnetic Resonance Imaging, 1990
- Superparamagnetic iron oxide-enhanced MR imaging: pulse sequence optimization for detection of liver cancer.Radiology, 1989
- Experimental lymph node metastases: enhanced detection with MR lymphography.Radiology, 1989
- A quantitative study of relaxation rate enhancement produced by iron oxide particles in polyacrylamide gels and tissueMagnetic Resonance in Medicine, 1989
- Effect of molecular weight (Mw) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJournal of Biomedical Materials Research, 1987